View source for 17769171. COMPOSITIONS AND METHODS FOR DETECTING PLXDC1 AND PLXCD2 IN HUMAN TISSUES simplified abstract (The Regents of the University of California)

=COMPOSITIONS AND METHODS FOR DETECTING PLXDC1 AND PLXCD2 IN HUMAN TISSUES=


==Organization Name==

[[:Category:The Regents of the University of California|The Regents of the University of California]]


[[Category:The Regents of the University of California]]

==Inventor(s)==

[[:Category:Hui Sun of Los Angeles CA (US)|Hui Sun of Los Angeles CA (US)]][[Category:Hui Sun of Los Angeles CA (US)]]

[[:Category:Adrian Chichuen Au of Los Angeles CA (US)|Adrian Chichuen Au of Los Angeles CA (US)]][[Category:Adrian Chichuen Au of Los Angeles CA (US)]]

[[:Category:Guo Cheng of Los Angeles CA (US)|Guo Cheng of Los Angeles CA (US)]][[Category:Guo Cheng of Los Angeles CA (US)]]

==COMPOSITIONS AND METHODS FOR DETECTING PLXDC1 AND PLXCD2 IN HUMAN TISSUES - A simplified explanation of the abstract==


This abstract first appeared for US patent application 17769171 titled 'COMPOSITIONS AND METHODS FOR DETECTING PLXDC1 AND PLXCD2 IN HUMAN TISSUES

==Simplified Explanation==

The present disclosure is about methods for preparing a tissue sample for detecting the expression of transmembrane proteins PLXDC1 or PLXDC2, as well as providing antibodies and treatments for tumor samples expressing these proteins.

* Detection of transmembrane protein expression in tissue samples
* Targeting tumor samples expressing PLXDC1 or PLXDC2 proteins with antibodies and treatments

== Potential Applications ==
This technology could be used in:
* Cancer research
* Drug development targeting PLXDC1 and PLXDC2 proteins

== Problems Solved ==
This technology helps in:
* Identifying transmembrane protein expression in tissue samples
* Targeting tumor samples expressing specific proteins for treatment

== Benefits ==
The benefits of this technology include:
* Improved detection of transmembrane protein expression
* Targeted treatments for tumors expressing PLXDC1 or PLXDC2 proteins

== Potential Commercial Applications ==
A potential commercial application of this technology could be:
* Developing diagnostic tools for detecting transmembrane protein expression in tumors

== Possible Prior Art ==
One possible prior art could be:
* Methods for detecting protein expression in tissue samples using immunohistochemistry

=== What are the specific methods for preparing a tissue sample for detection of transmembrane protein expression? ===

The specific methods for preparing a tissue sample for detection of transmembrane protein expression involve sample collection, processing, and analysis using techniques such as immunohistochemistry.

=== How do the antibodies and treatments target tumor samples expressing PLXDC1 or PLXDC2 proteins? ===

The antibodies and treatments target tumor samples expressing PLXDC1 or PLXDC2 proteins by specifically binding to these proteins and inhibiting their function, leading to potential therapeutic effects.


==Original Abstract Submitted==

The present disclosure relates generally to methods for preparing a tissue sample for detection of the expression of a transmembrane protein in the tissue sample. The present disclosure also provides antibodies and treatments targeting tumor samples expressing the PLXDC1 or the PLXDC2 proteins.



[[Category:G01N33/574]]
[[Category:C07K16/28]]
[[Category:G01N1/30]]